HGH (Somatropin) vs PEG-MGF

Side-by-side comparison of mechanisms, dosing, interactions, and stacking potential.

HGH (Somatropin)PEG-MGF
CategoryGrowth FactorsGrowth Factors
Standard DoseResearch indicates 1-2 IU daily for anti-aging and general optimization. 2-4 IU daily for body composition. 4-8+ IU daily in clinical GH deficiency (physician-supervised only).
TimingBedtime injection (mimics natural nocturnal GH surge) or morning fasted. Split dosing (AM + pre-bed) for higher doses. Always on empty stomach — carbohydrates blunt GH action.
Cycle DurationContinuous use is common in anti-aging protocols. 6-12 month minimum for full benefits. Clinical GHD treatment is typically lifelong.
Evidence Levelstrong_humanPreclinical
A

HGH (Somatropin)

Growth Factors

Mechanism

Human Growth Hormone (somatropin) is a 191-amino acid single-chain polypeptide produced by anterior pituitary somatotrophs. It binds the GH receptor (GHR), activating JAK2-STAT5 signaling and MAP kinase pathways. Systemically, HGH upregulates hepatic IGF-1 production, which mediates most of its anabolic effects through IGF-1R/PI3K/Akt/mTOR-driven protein synthesis. Direct GH effects include lipolysis activation, insulin antagonism, chondrocyte/osteoblast stimulation, and enhanced collagen synthesis. Effects are divided into direct (lipolysis, insulin antagonism) and indirect (IGF-1-mediated growth and anabolism).

Standard Dosing

Research indicates 1-2 IU daily for anti-aging and general optimization. 2-4 IU daily for body composition. 4-8+ IU daily in clinical GH deficiency (physician-supervised only).

Timing

Bedtime injection (mimics natural nocturnal GH surge) or morning fasted. Split dosing (AM + pre-bed) for higher doses. Always on empty stomach — carbohydrates blunt GH action.

Cycle Duration

Continuous use is common in anti-aging protocols. 6-12 month minimum for full benefits. Clinical GHD treatment is typically lifelong.

Side Effects

  • Water retention/edema
  • Joint pain (arthralgia)
  • Carpal tunnel syndrome
  • Insulin resistance/elevated blood glucose
  • Gynecomastia
  • Numbness/tingling
  • Headache
  • Potential organ growth at high doses
  • Jaw/hand growth with chronic supraphysiological use

Contraindications

  • Active cancer or active tumors
  • Diabetic retinopathy (proliferative)
  • Acute critical illness
  • Closed epiphyses with active acromegaly features
  • Prader-Willi syndrome with severe obesity/respiratory impairment
  • Pregnancy and breastfeeding

Best Stacking Partners

CJC-1295/Ipamorelin (use one or the other — not GHS + exogenous GH)BPC-157TB-500
B

PEG-MGF

Growth Factors

Mechanism

Pegylated mechano growth factor analog discussed in muscle repair and hypertrophy contexts with limited human evidence.

Contraindications

  • Research-use compound with limited safety data

Not sure which is right for you?

Take our free assessment to get personalized recommendations based on your health goals, current stack, and biomarkers.

Get Your Free Protocol →or take the assessment →